MedPath
TGA Approval

Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag (312686)

312686

Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag

Novartis Pharmaceuticals Australia Pty Ltd

December 19, 2018

Biological

Biological

Active

Included

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-02121-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-02122-1

Active Ingredients

tisagenlecleucel

© Copyright 2025. All Rights Reserved by MedPath